Enhanced acute lung damage following corticosteroid treatment
- PMID: 6465679
- DOI: 10.1164/arrd.1984.130.2.256
Enhanced acute lung damage following corticosteroid treatment
Abstract
The administration of butylated hydroxytoluene (BHT) to mice has been shown to produce diffuse alveolar epithelial cell damage, which is largely resolved within 2 wk. Treatment with the corticosteroid prednisolone, 30 mg/kg twice daily during the first 5 days after BHT, greatly exacerbated the initial damage. A severe interstitial pneumonitis was evident histologically 15 days after BHT-treatment. The infiltrate became even more extensive 22 days after BHT with a massive consolidation of the lungs. The pneumonitis was characterized by cellular infiltrates, alveolar thickening, and the deposition of fibrillar collagenous material. This massive steroid-induced pneumonitis was virtually gone at 60 days after BHT-treatment. The extent of the fibrotic changes, as quantitated by measuring total lung hydroxyproline levels, was dependent both on the corticosteroid dose and the time when they were administered. Increases in total lung hydroxyproline were seen following the administration of 30 mg/kg prednisolone or methylprednisolone acetate twice daily on Days 1 to 5 after BHT. These biochemical changes were evident 15 days after BHT and, in contrast to the histologic findings, persisted to Day 60. The administration of prednisolone on Days 3 to 7, 6 to 10, or 1 to 10 after BHT, or at a lower doses had no effect on the development of fibrosis. Single 30 mg/kg doses of prednisolone and methylprednisolone acetate inhibited the increased lung DNA synthesis normally seen after BHT. This inhibition was maintained by twice daily doses of prednisolone on Days 1 to 5 after BHT, and was followed by a rebound in DNA synthesis on Day 7.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Enhanced acute lung damage in mice following administration of 1,3-bis(2-chloroethyl)-1-nitrosourea.Cancer Res. 1985 Nov;45(11 Pt 2):5707-13. Cancer Res. 1985. PMID: 4053044
-
The effect of indomethacin, prednisolone and cis-4-hydroxyproline on pulmonary fibrosis produced by butylated hydroxytoluene and oxygen.Toxicology. 1981;20(4):281-8. doi: 10.1016/0300-483x(81)90035-4. Toxicology. 1981. PMID: 7314119
-
Protection by methylprednisolone against butylated hydroxytoluene-induced pulmonary damage and impairment of microsomal monooxygenase activities in the mouse: lack of effect on fibrosis.Exp Lung Res. 1986;10(1):1-22. doi: 10.3109/01902148609057500. Exp Lung Res. 1986. PMID: 3948809
-
Collagen synthesis and degradation in acutely damaged mouse lung tissue following treatment with prednisolone.Biochem Pharmacol. 1985 Jul 15;34(14):2519-24. doi: 10.1016/0006-2952(85)90536-2. Biochem Pharmacol. 1985. PMID: 4015692
-
The role of toxicological interactions in lung injury.Environ Health Perspect. 1984 Apr;55:139-48. doi: 10.1289/ehp.8455139. Environ Health Perspect. 1984. PMID: 6376096 Free PMC article. Review.
Cited by
-
Exploring pharmacological strategies in the management of ARDS: Efficacy, limitations, and future directions.J Crit Care Med (Targu Mures). 2025 Jul 31;11(3):208-220. doi: 10.2478/jccm-2025-0030. eCollection 2025 Jul. J Crit Care Med (Targu Mures). 2025. PMID: 40765544 Free PMC article. Review.
-
Pathophysiology of acute respiratory distress syndrome. Glucocorticoid receptor-mediated regulation of inflammation and response to prolonged glucocorticoid treatment.Presse Med. 2011 Dec;40(12 Pt 2):e543-60. doi: 10.1016/j.lpm.2011.04.023. Epub 2011 Nov 15. Presse Med. 2011. PMID: 22088618 Free PMC article. Review.
-
Pharmacological principles guiding prolonged glucocorticoid treatment in ARDS.Intensive Care Med. 2020 Dec;46(12):2284-2296. doi: 10.1007/s00134-020-06289-8. Epub 2020 Nov 4. Intensive Care Med. 2020. PMID: 33150472 Free PMC article. Review.
-
Rationale for Prolonged Glucocorticoid Use in Pediatric ARDS: What the Adults Can Teach Us.Front Pediatr. 2016 Jun 14;4:58. doi: 10.3389/fped.2016.00058. eCollection 2016. Front Pediatr. 2016. PMID: 27379217 Free PMC article. Review.
-
Myofibroblast repair mechanisms post-inflammatory response: a fibrotic perspective.Inflamm Res. 2017 Jun;66(6):451-465. doi: 10.1007/s00011-016-1019-x. Epub 2016 Dec 31. Inflamm Res. 2017. PMID: 28040859 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical